PT - JOURNAL ARTICLE AU - Das, Raunak Kumar AU - Pal, Mousumi AU - Barui, Ananya AU - Paul, Ranjan Rashmi AU - Chakraborty, Chandan AU - Ray, Ajoy Kumar AU - Sengupta, Sanghamitra AU - Chatterjee, Jyotirmoy TI - Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression AID - 10.1136/jcp.2010.078964 DP - 2010 Oct 01 TA - Journal of Clinical Pathology PG - 894--899 VI - 63 IP - 10 4099 - http://jcp.bmj.com/content/63/10/894.short 4100 - http://jcp.bmj.com/content/63/10/894.full SO - J Clin Pathol2010 Oct 01; 63 AB - Background The assessment of malignant potential of oral submucous fibrosis grades vis-à-vis their progression towards malignancy is associated with expression of possible multiple molecular markers.Aims To analyse p63, E-cadherin and CD105 expression in this premalignant pathosis with a view to unravel and understand the expression of these molecules as markers.Methods The oral mucosal biopsies (normal, oral submucous fibrosis with and without dysplasia) were studied with routine H&E, and by immunohistochemistry for p63, E-cadherin and CD105 expression. p63 was assessed as percentage of positive nuclei. E-cadherin expression was estimated through (i) distance between basement membrane and E-cadherin expression initiation point, (ii) ratio between epithelial thickness and epithelial thickness displaying E-cadherin, and (iii) E-cadherin intensity variation along the expression path. CD105 expression was assessed qualitatively.Results The p63+ cells were highest in severely dysplastic tissues followed by other dysplastic grades, normal oral mucosa and non-dysplastic conditions. However, the p63+ cells displayed the feature of progressive maturation only in normal mucosa. There was a loss of membranous E-cadherin in basal layers of all diseased conditions; it was highest in severe dysplasia. There was significant variation (p<0.0001) in E-cadherin intensity within and between the tissues (normal and diseased). CD105 expression increased abruptly in dysplasia.Conclusions The malignant potential of this pre-cancerous condition is likely to be correlated with an increase in p63 and CD105 expression and a concomitant loss of membranous E-cadherin. This may lead to marker identification through greater validation.